{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:03:08Z","timestamp":1786719788652,"version":"build-2736575974"},"reference-count":56,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["P-9\/ECD\/Adhoc\/57\/2019-2020"],"award-info":[{"award-number":["P-9\/ECD\/Adhoc\/57\/2019-2020"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/006912"],"award-info":[{"award-number":["CRG\/2023\/006912"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["A-59"],"award-info":[{"award-number":["A-59"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Biotechnology , Ministry of Science and Technology","award":["BT\/PR59631\/BMS2\/156\/227\/2025"],"award-info":[{"award-number":["BT\/PR59631\/BMS2\/156\/227\/2025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The continued emergence of SARS-CoV-2 variants worldwide underscores the need for effective measures to combat the current and future outbreaks. The receptor-binding domain (RBD) of the spike glycoprotein plays a critical role in viral entry and represents a highly immunogenic target. In this study, we generated a mouse-derived single-chain variable fragment (scFv) phage display library against the RBD of the SARS-CoV-2 spike protein. Peptide ELISA-based epitope mapping demonstrated that selected monoclonal scFv phages exhibited broad epitope recognition and reactivity across multiple recently reported variants. In a SARS-CoV-2 pseudovirus neutralization assay, scFv C4 showed potent neutralizing activity against the wild-type, Gamma, and Delta variants, with IC50 values below 4 \u03bcg\/mL. These findings highlight the potential utility of these scFvs as candidate reagents for the development of improved diagnostic platforms and as scaffolds for next-generation monoclonal antibody-based therapeutics.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6c00269","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:13:31Z","timestamp":1785154411000},"page":"2739-2749","source":"Crossref","is-referenced-by-count":0,"title":["Anti-RBD Single-Chain Variable Fragments Library (scFv\nLibrary) Generation toward the Development of a Diagnostic Platform\nfor SARS-CoV-2"],"prefix":"10.1021","volume":"12","author":[{"given":"Mohd Shoeb","family":"Alam","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Sharma","sequence":"additional","affiliation":[{"name":"National Institute of Biologicals , , ,","place":["Noida, Uttar Pradesh, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romisa","family":"Razvi","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8704-8750","authenticated-orcid":true,"given":"Harsh","family":"Bhakhri","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulsum","family":"Fatima","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Sachdeva","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Tripathi","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-2867","authenticated-orcid":true,"given":"Kalpana","family":"Luthra","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-053X","authenticated-orcid":true,"given":"Sumit","family":"Rathore","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , , ,","place":["New Delhi, India, 110029"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"11","key":"2026081410075885600_cit1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology\nof SARS-CoV-2 and implications for therapeutic\ndevelopment","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"2026081410075885600_cit2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular Architecture of the SARS-CoV-2 Virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"issue":"7807","key":"2026081410075885600_cit3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2\nspike receptor-binding domain bound to\nthe ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"25","key":"2026081410075885600_cit4","doi-asserted-by":"publisher","first-page":"13967","DOI":"10.1073\/pnas.2008209117","article-title":"Enhanced receptor\nbinding of SARS-CoV-2 through networks\nof hydrogen-bonding and hydrophobic interactions","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"2026081410075885600_cit5","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody Responses\nto SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"2026081410075885600_cit6","doi-asserted-by":"publisher","first-page":"12814","DOI":"10.1074\/jbc.AC120.014918","article-title":"Rajesh Kumar Identification of an anti\u2013SARS\u2013CoV-2\nreceptor-binding domain\u2013directed human monoclonal antibody\nfrom a nai\u0308ve semisynthetic library","volume":"295","author":"Hilal Ahmad Parray","year":"2020","journal-title":"J.\nBiol. Chem."},{"key":"2026081410075885600_cit7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/s1473-3099(20)30141-9","article-title":"Convalescent plasma\nas a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet\nInfect Dis"},{"issue":"10","key":"2026081410075885600_cit8","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID-19 patients\nin Wuhan, China","volume":"92","author":"Ye","year":"2020","journal-title":"J. Med. Virol."},{"issue":"2","key":"2026081410075885600_cit9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies\nbased on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"2026081410075885600_cit10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010248","article-title":"A SARS-CoV-2\nvariant elicits an antibody response with\na shifted immunodominance hierarchy","volume":"18","author":"Greaney","year":"2022","journal-title":"PLoS pathogens"},{"key":"2026081410075885600_cit11","doi-asserted-by":"publisher","first-page":"114861","DOI":"10.1016\/j.bios.2022.114861","article-title":"A high-throughput fully automatic\nbiosensing platform\nfor efficient COVID-19 detection","volume":"220","author":"Rong","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"10","key":"2026081410075885600_cit12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/bios12100900","article-title":"A Closed-Loop\nApproach to Fight Coronavirus: Early Detection and Subsequent Treatment","volume":"12","author":"Rong","year":"2022","journal-title":"Biosensors"},{"key":"2026081410075885600_cit13","doi-asserted-by":"publisher","first-page":"112868","DOI":"10.1016\/j.bios.2020.112868","article-title":"Development of a SARS-CoV-2-specific\nbiosensor for antigen detection using scFv-Fc fusion proteins","volume":"175","author":"Kim","year":"2021","journal-title":"Biosens. Bioelectron."},{"issue":"3","key":"2026081410075885600_cit14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/antib8030044","article-title":"Phage Display\nLibraries for Antibody Therapeutic Discovery and Development","volume":"8","author":"Almagro","year":"2019","journal-title":"Antibodies"},{"key":"2026081410075885600_cit15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1472-6750-11-39","article-title":"Target-selective homologous recombination\ncloning for high-throughput generation of monoclonal antibodies from\nsingle plasma cells","volume":"11","author":"Kurosawa","year":"2011","journal-title":"BMC Biotechnol."},{"key":"2026081410075885600_cit16","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.27.465996","article-title":"Camel nanobodies broadly neutralize SARS-CoV-2 variants","author":"Hong","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"2026081410075885600_cit17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13568-022-01355-4","article-title":"Specific anti-SARS-CoV-2\nS1 IgY-scFv is a promising tool for recognition of the virus","volume":"12","author":"Ge","year":"2022","journal-title":"AMB Express"},{"issue":"1","key":"2026081410075885600_cit18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41421-021-00295-w","article-title":"Screening\nof potent neutralizing antibodies against SARS-CoV-2 using convalescent\npatients-derived phage-display libraries","volume":"7","author":"Pan","year":"2021","journal-title":"Cell\nDiscovery"},{"issue":"7898","key":"2026081410075885600_cit19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing\nSARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"15","key":"2026081410075885600_cit20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMc2201933","article-title":"Efficacy of Antiviral Agents against the SARS-CoV-2\nOmicron Subvariant BA.2","volume":"386","author":"Takashita","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026081410075885600_cit21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMc2214302","article-title":"Efficacy of Antiviral\nAgents against Omicron Subvariants BQ.1.1 and XBB","volume":"388","author":"Imai","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2026081410075885600_cit22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.20411\/pai.v9i2.718","article-title":"Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal\nAntibody Therapy on Neutralizing Antibody Response","volume":"9","author":"Paul","year":"2024","journal-title":"Pathog. Immun."},{"issue":"3","key":"2026081410075885600_cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.11.004","article-title":"Diagnostic accuracy\nof SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals\nin the omicron period: A cross-sectional study","volume":"29","author":"Venekamp","year":"2023","journal-title":"Clin. Microbiol. Infect"},{"key":"2026081410075885600_cit24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7554\/eLife.95708","article-title":"Role of N343 glycosylation\non the\nSARS-CoV-2 S RBD structure and co-receptor binding across variants\nof concern","volume":"13","author":"Ives","year":"2024","journal-title":"Elife"},{"issue":"6501","key":"2026081410075885600_cit25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific\nglycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"2026081410075885600_cit26","doi-asserted-by":"publisher","first-page":"935573","DOI":"10.3389\/fimmu.2022.935573","article-title":"Display of receptor-binding domain of SARS-CoV-2 Spike\nprotein variants on the Saccharomyces cerevisiae cell surface","volume":"13","author":"Xing","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"2026081410075885600_cit27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/biology13040207","article-title":"Influence of Mutations and N-Glycosylation\nSites in the Receptor-Binding Domain (RBD) and the Membrane Protein\nof SARS-CoV-2 Variants of Concern on Antibody Binding in ELISA","volume":"13","author":"Schwarze","year":"2024","journal-title":"Biology"},{"key":"2026081410075885600_cit28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbt.2022.08.002","article-title":"An engineered\nSARS-CoV-2 receptor-binding domain produced in Pichia pastoris as\na candidate vaccine antigen","volume":"72","author":"Limonta-Fernandez","year":"2022","journal-title":"N. Biotechnol."},{"key":"2026081410075885600_cit29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","article-title":"The\nglycosylation in SARS-CoV-2 and its receptor ACE2","volume":"6","author":"Gong","year":"2021","journal-title":"nature"},{"key":"2026081410075885600_cit30","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1074\/jbc.RA119.007532","article-title":"Glycosylation of\nthe viral attachment protein of avian\ncoronavirus is essential for host cell and receptor binding","volume":"294","author":"Parsons","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026081410075885600_cit31","doi-asserted-by":"publisher","first-page":"21779","DOI":"10.1038\/s41598-020-78711-6","article-title":"Structural and functional comparison of SARS-CoV-2-spike\nreceptor binding domain produced in Pichia pastoris and mammalian\ncells","volume":"10","author":"Argentinian AntiCovid","year":"2020","journal-title":"Sci. Rep."},{"key":"2026081410075885600_cit32","volume-title":"BALB\/c Mous; Brenner\u2019s\nEncyclopedia of Genetics","author":"Nakamura","year":"2013","edition":"2nd"},{"issue":"15","key":"2026081410075885600_cit33","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.vaccine.2018.02.115","article-title":"Vaccination of sheep\nwith Quil-A\u00ae adjuvant expands the antibody repertoire to the\nFasciola MF6p\/FhHDM-1 antigen and administered together impair the\ngrowth and antigen release of flukes","volume":"36","author":"Orbegozo-Medina","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"2026081410075885600_cit34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177574","article-title":"Assessment of antibody library diversity through next\ngeneration sequencing and technical error compensation","volume":"12","author":"Fantini","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"2026081410075885600_cit35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.biologicals.2013.04.001","article-title":"Phage display antibodies for diagnostic\napplications","volume":"41","author":"Hairul Bahara","year":"2013","journal-title":"J. Int. Association Of Biol. Stand."},{"key":"2026081410075885600_cit36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2016.00388","article-title":"Significant Differences in Physicochemical Properties\nof Human Immunoglobulin Kappa and Lambda CDR3 Regions","volume":"7","author":"Townsend","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"2026081410075885600_cit37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4161\/mabs.1.4.8635","article-title":"Non-human primate immune\nlibraries combined with germline\nhumanization: An (almost) new, and powerful approach for the isolation\nof therapeutic antibodies","volume":"1","author":"Pelat","year":"2009","journal-title":"MAbs"},{"issue":"9","key":"2026081410075885600_cit38","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1128\/iai.65.9.3743-3752.1997","article-title":"Molecular characterization\nof murine humoral immune response to botulinum neurotoxin type A binding\ndomain as assessed by using phage antibody libraries","volume":"65","author":"Amersdorfer","year":"1997","journal-title":"Infect. Immun."},{"issue":"8","key":"2026081410075885600_cit39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043471","article-title":"Transferring the characteristics\nof naturally occurring and biased antibody repertoires to human antibody\nlibraries by trapping CDRH3 sequences","volume":"7","author":"Venet","year":"2012","journal-title":"PLoS\nOne"},{"issue":"2","key":"2026081410075885600_cit40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010260","article-title":"Structural and antigenic\nvariations\nin the spike protein of emerging SARS-CoV-2 variants","volume":"18","author":"Mittal","year":"2022","journal-title":"PLoS Pathog."},{"key":"2026081410075885600_cit41","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.04.471236","article-title":"An antibody-escape\ncalculator for mutations to the SARS-CoV-2 receptor-binding domain","author":"Greaney","year":"2021","journal-title":"bioRxiv"},{"issue":"7871","key":"2026081410075885600_cit42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity\nof SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"issue":"16","key":"2026081410075885600_cit43","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1016\/j.cell.2021.06.020","article-title":"Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine\nand convalescent serum","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"issue":"4","key":"2026081410075885600_cit44","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s40121-021-00525-4","article-title":"Efficacy of\nBamlanivimab\/Etesevimab and Casirivimab\/Imdevimab in Preventing Progression\nto Severe COVID-19 and Role of Variants of Concern","volume":"10","author":"Falcone","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"4","key":"2026081410075885600_cit45","doi-asserted-by":"publisher","first-page":"109433","DOI":"10.1016\/j.celrep.2021.109433","article-title":"A SARS-CoV-2\nneutralizing antibody selected from COVID-19 patients binds to the\nACE2-RBD interface and is tolerant to most known RBD mutations","volume":"36","author":"Bertoglio","year":"2021","journal-title":"Cell Rep."},{"issue":"6506","key":"2026081410075885600_cit46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies\nin humanized mice and convalescent humans yield a SARS-CoV-2 antibody\ncocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"issue":"2","key":"2026081410075885600_cit47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biom15020301","article-title":"Epimaps\nof the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights\ninto Protein Stability, Epitope Prediction, and Antibody Binding","volume":"15","author":"Pitsillou","year":"2025","journal-title":"Biomolecules"},{"issue":"593","key":"2026081410075885600_cit48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody,\nLY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"2026081410075885600_cit49","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02697-21","article-title":"The Linker Region Promotes\nActivity and Binding Efficiency of Modular LPMO towards Polymeric\nSubstrate","volume":"10","author":"Srivastava","year":"2022","journal-title":"Microbiol. Spectrum."},{"issue":"5","key":"2026081410075885600_cit50","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/nar\/22.5.888","article-title":"Optimization\nof primer sequences\nfor mouse scFv repertoire display library construction","volume":"22","author":"Zhou","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"2026081410075885600_cit51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fimmu.2015.00440","article-title":"Diagnostic Potential\nof Recombinant scFv Antibodies Generated Against Hemagglutinin Protein\nof Influenza A Virus","volume":"6","author":"Rajput","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"2026081410075885600_cit52","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1101\/pdb.prot5633","article-title":"IMGT\/V-QUEST:\nIMGT standardized analysis\nof the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"issue":"Web Server issue","key":"2026081410075885600_cit53","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: The highly customized\nand integrated system for IG and TR standardized V-J and V-D-J sequence\nanalysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"33","key":"2026081410075885600_cit54","doi-asserted-by":"publisher","first-page":"20257","DOI":"10.1074\/jbc.M115.644906","article-title":"Interaction\nof Plasmodium vivax Tryptophan-rich Antigen\nPvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite\nGrowth","volume":"290","author":"Alam","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"9","key":"2026081410075885600_cit55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009958","article-title":"Cross-neutralization\nof SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and\npolyclonal plasma","volume":"17","author":"Mishra","year":"2021","journal-title":"PLoS Pathog."},{"issue":"11","key":"2026081410075885600_cit56","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling\nof biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6c00269","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2739\/66281643\/acsinfecdis.6c00269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2739\/66281643\/acsinfecdis.6c00269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:21:36Z","timestamp":1786717296000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/12\/8\/2739\/5234074\/Anti-RBD-Single-Chain-Variable-Fragments-Library"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,27]]},"published-print":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6c00269","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}